Neoadjuvant Pressurized Intraperitoneal Aerosol Chemotherapy for Conversion to Cytoreductive Surgery in Unresectable Malignant Peritoneal Mesothelioma: A Report of 2 Cases
{{output}}
BACKGROUND Peritoneal mesothelioma (PM) is the second most common presentation site of malignant mesothelioma. The standard of care for PM is cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Because of its insidious ... ...
